公司資料
Achilles Therapeutics 股價、新聞與催化劑
- 股票代碼:
- ACHL
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United Kingdom
股價為何變動
Current closing-price context is not available for ACHL.
公司概覽
業務概覽
Achilles Therapeutics was a T-cell and immunology company focused on precision cancer treatment before its restructuring and public-market decline. Its platform centered on clonal neoantigen targeting.
所在地與產業分類
Headquartered in the United Kingdom and listed on NASDAQ as an ADR before restructuring, Achilles sat in oncology biotechnology.
商業模式特徵
The company depended on clinical validation, platform science, and the ability to translate T-cell biology into value.
生技產業定位
Achilles belongs to the historical cell-therapy and restructuring category rather than the current live set.
未來催化劑
- Achilles Therapeutics’s catalysts are its T-cell program and any update that clarifies whether the company can keep its solid-tumor platform alive. The stock still depends on human proof.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。